Efficiency and Safety of AAV-mediated Gene Delivery of the Human ND4 Complex I Subunit in the Mouse Visual System

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2009 Apr 24

PMID 19387075

Citations 47

Authors

John Guy

Xiaoping Qi

Rajeshwari D Koilkonda

Tania Arguello

Tsung-Han Chou

Marco Ruggeri

Vittorio Porciatti

Alfred S Lewin

William W Hauswirth

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the efficiency and safety of AAV-mediated gene delivery of a normal human ND4 complex I subunit in the mouse visual system.

Methods: A nuclear encoded human ND4 subunit fused to the ATPc mitochondrial targeting sequence and FLAG epitope were packaged in AAV2 capsids that were injected into the right eyes of mice. AAV-GFP was injected into the left eyes. One month later, pattern electroretinography (PERG), rate of ATP synthesis, gene expression, and incorporation of the human ND4 subunit into the murine complex I were evaluated. Quantitative analysis of ND4FLAG-injected eyes was assessed compared with green fluorescent protein (GFP)-injected eyes.

Results: Rates of ATP synthesis and PERG amplitudes were similar in ND4FLAG- and GFP-inoculated eyes. PERG latency was shorter in eyes that received ND4FLAG. Immunoprecipitated murine complex I gave the expected 52-kDa band of processed human ND4FLAG. Confocal microscopy revealed perinuclear expression of FLAG colocalized with mitochondria-specific fluorescent dye. Transmission electron microscopy revealed FLAG immunogold within mitochondria. Compared with Thy1.2-positive retinal ganglion cells (RGCs), quantification was 38% for FLAG-positive RGCs and 65% for GFP-positive RGCs. Thy1.2 positive-RGC counts in AAV-ND4FLAG were similar to counts in control eyes injected with AAV-GFP.

Conclusions: Human ND4 was properly processed and imported into the mitochondria of RGCs and axons of mouse optic nerve after intravitreal injection. Although it had approximately two-thirds the efficiency of GFP, the expression of normal human ND4 in murine mitochondria did not induce the loss of RGCs, ATP synthesis, or PERG amplitude, suggesting that allotopic ND4 may be safe for the treatment of patients with Leber hereditary optic neuropathy.

Citing Articles

MSC-mediated mitochondrial transfer restores mitochondrial DNA and function in neural progenitor cells of Leber's hereditary optic neuropathy.

Wang R, Bao F, Lu M, Jia X, Xiao J, Wu Y Sci China Life Sci. 2024; 67(11):2511-2519.

PMID: 39134891 DOI: 10.1007/s11427-024-2647-8.

Current advances in gene therapy of mitochondrial diseases.

Soldatov V, Kubekina M, Skorkina M, Belykh A, Egorova T, Korokin M J Transl Med. 2022; 20(1):562.

PMID: 36471396 PMC: 9724384. DOI: 10.1186/s12967-022-03685-0.

From Bench to Bedside-Delivering Gene Therapy for Leber Hereditary Optic Neuropathy.

Chen B, Yu-Wai-Man P Cold Spring Harb Perspect Med. 2022; 12(6).

PMID: 35863905 PMC: 9310952. DOI: 10.1101/cshperspect.a041282.

The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease.

Ji M, Kreymerman A, Belle K, Ghiam B, Muscat S, Mahajan V Transl Vis Sci Technol. 2021; 10(8):4.

PMID: 34232272 PMC: 8267180. DOI: 10.1167/tvst.10.8.4.

Mitochondrial function in development and disease.

Rossmann M, Dubois S, Agarwal S, Zon L Dis Model Mech. 2021; 14(6).

PMID: 34114603 PMC: 8214736. DOI: 10.1242/dmm.048912.

References

Qi X, Sun L, Lewin A, Hauswirth W, Guy J . The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse. Invest Ophthalmol Vis Sci. 2007; 48(1):1-10. DOI: 10.1167/iovs.06-0789. View

DiMauro S, Hirano M, Schon E . Approaches to the treatment of mitochondrial diseases. Muscle Nerve. 2006; 34(3):265-83. DOI: 10.1002/mus.20598. View

Glick B, Schatz G . Import of proteins into mitochondria. Annu Rev Genet. 1991; 25:21-44. DOI: 10.1146/annurev.ge.25.120191.000321. View

Wallace D, Singh G, Lott M, Hodge J, Schurr T, Lezza A . Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988; 242(4884):1427-30. DOI: 10.1126/science.3201231. View

Esposito L, Melov S, Panov A, Cottrell B, Wallace D . Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci U S A. 1999; 96(9):4820-5. PMC: 21775. DOI: 10.1073/pnas.96.9.4820. View

Manfredi G, Fu J, Ojaimi J, Sadlock J, Kwong J, Guy J . Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet. 2002; 30(4):394-9. DOI: 10.1038/ng851. View

Newman N, Biousse V, David R, Bhatti M, Hamilton S, Farris B . Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am J Ophthalmol. 2005; 140(3):407-15. DOI: 10.1016/j.ajo.2005.03.058. View

Ventura L, Sorokac N, De los Santos R, Feuer W, Porciatti V . The relationship between retinal ganglion cell function and retinal nerve fiber thickness in early glaucoma. Invest Ophthalmol Vis Sci. 2006; 47(9):3904-11. PMC: 1808329. DOI: 10.1167/iovs.06-0161. View

Seo B, Nakamaru-Ogiso E, Flotte T, Matsuno-Yagi A, Yagi T . In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease. J Biol Chem. 2006; 281(20):14250-5. DOI: 10.1074/jbc.M600922200. View

10.

McCarty D, Fu H, Monahan P, Toulson C, Naik P, Samulski R . Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther. 2003; 10(26):2112-8. DOI: 10.1038/sj.gt.3302134. View

11.

Bayona-Bafaluy M, Blits B, Battersby B, Shoubridge E, Moraes C . Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease. Proc Natl Acad Sci U S A. 2005; 102(40):14392-7. PMC: 1242285. DOI: 10.1073/pnas.0502896102. View

12.

Zhong L, Li B, Jayandharan G, Mah C, Govindasamy L, Agbandje-Mckenna M . Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. Virology. 2008; 381(2):194-202. PMC: 2643069. DOI: 10.1016/j.virol.2008.08.027. View

13.

Hauswirth W, Lewin A, Zolotukhin S, Muzyczka N . Production and purification of recombinant adeno-associated virus. Methods Enzymol. 2000; 316:743-61. DOI: 10.1016/s0076-6879(00)16760-6. View

14.

Hauswirth W, Aleman T, Kaushal S, Cideciyan A, Schwartz S, Wang L . Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. Hum Gene Ther. 2008; 19(10):979-90. PMC: 2940541. DOI: 10.1089/hum.2008.107. View

15.

Ruggeri M, Wehbe H, Jiao S, Gregori G, Jockovich M, Hackam A . In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2007; 48(4):1808-14. DOI: 10.1167/iovs.06-0815. View

16.

Zhong L, Li B, Mah C, Govindasamy L, Agbandje-Mckenna M, Cooper M . Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Natl Acad Sci U S A. 2008; 105(22):7827-32. PMC: 2402387. DOI: 10.1073/pnas.0802866105. View

17.

Porciatti V . The mouse pattern electroretinogram. Doc Ophthalmol. 2007; 115(3):145-53. PMC: 2773675. DOI: 10.1007/s10633-007-9059-8. View

18.

Porciatti V, Ventura L . Adaptive changes of inner retina function in response to sustained pattern stimulation. Vision Res. 2009; 49(5):505-13. PMC: 2656435. DOI: 10.1016/j.visres.2008.12.001. View

19.

Guy J, Qi X, Muzyczka N, Hauswirth W . Reporter expression persists 1 year after adeno-associated virus-mediated gene transfer to the optic nerve. Arch Ophthalmol. 1999; 117(7):929-37. DOI: 10.1001/archopht.117.7.929. View

20.

Dudus L, Anand V, Acland G, Chen S, Wilson J, Fisher K . Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vision Res. 1999; 39(15):2545-53. DOI: 10.1016/s0042-6989(98)00308-3. View